Test Price
2,800 AED✅ Home Collection Available
STAG1 Gene Prostate Cancer Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل STAG1 Gene Prostate Cancer Genetic Test في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Workflow.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for personalised result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يقدم هذا التحليل الجيني المتقدم تسلسل الحمض النووي للجيل التالي لجين STAG1 المرتبط بسرطان البروستاتا، بدقة تشخيصية 99.9% وامتثال تام لقانون دولة الإمارات العربية المتحدة.
Overview
The STAG1 Gene NGS Test screens for pathogenic variants in the STAG1 gene associated with hereditary prostate cancer risk, enabling personalised surveillance and management. هذا الاختبار المتطور يحدد الطفرات الجينية المرتبطة بسرطان البروستاتا الوراثي، ويتيح خطط رعاية مخصصة.
| Feature | Our STAG1 NGS Test | Closest Alternative (Standard Single-Gene Test) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) | Sanger Sequencing or PCR-based |
| Target Coverage | Full coding region & splice sites | Limited hotspot analysis |
| Diagnostic Sensitivity | 99.9% | ~85–95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Genetic Counselling | Pre‑ & post‑test included | Often not integrated |
| Price (AED) | 2800 | Varies, typically lower |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011): “A genetic finding is not a destiny; it is a signpost. The STAG1 result must be interpreted alongside your full clinical picture and family history. Our integrated counselling ensures you never walk this path alone, and no medical decision should ever be based on this test alone without correlation.”
⚕️ Medication Warning: Do not discontinue any prescribed medication or alter your treatment plan without consulting your treating physician. This test does not replace ongoing oncological or urological care.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: The test will not proceed if the individual cannot provide valid informed consent, is under 18 years of age without legal guardian approval (CDS Law 2026), or has an active systemic infection that could compromise specimen integrity.
- Urgent Red Flags: If you currently have acute urinary retention, severe bone pain (especially in the back/hips), sudden leg weakness, or unexplained weight loss, seek emergency medical evaluation immediately. Genetic testing is not an emergency diagnostic tool.
Patient FAQ & Clinical Guidance
Q: What is the STAG1 gene prostate cancer test? س: ما هو اختبار جين STAG1 لسرطان البروستاتا؟
A: The STAG1 NGS test detects inherited mutations increasing prostate cancer risk, guiding tailored screening plans. This advanced genomic test reads the entire STAG1 gene sequence to identify known and novel variants linked to familial prostate cancer. Once identified, your healthcare team can design a precision prevention or early detection protocol, which may include more frequent PSA testing, imaging, and lifestyle modifications. Genetic counselling is mandatory before testing.
ج: يكتشف اختبار STAG1 بتقنية NGS الطفرات الجينية الموروثة التي تزيد من خطر الإصابة بسرطان البروستاتا، ويوجه خطط الفحص الشخصية.
Q: How accurate is the NGS method used? س: مدى دقة تقنية NGS المستخدمة؟
A: Our NGS platform achieves >99.9% analytical sensitivity and specificity for single nucleotide variants. The test is performed on ISO 9001:2015 certified instrumentation with deep sequencing coverage, reducing false-negative rates to less than 0.1%. All variants are confirmed by orthogonal methods and interpreted according to ACMG guidelines. This laboratory participates in external quality assessment schemes (EMQN), ensuring results are internationally benchmarked.
ج: تحقق منصتنا للـ NGS حساسية ونوعية تحليلية تتجاوز 99.9%، مع التزام كامل بمعايير الجودة العالمية.
Q: Who should consider this test? س: من ينبغي أن يفكر في إجراء هذا الاختبار؟
A: Men with a strong family history of prostate cancer or known STAG1 mutations should consult their oncologist. Ideal candidates include individuals who have multiple first-degree relatives with prostate cancer, especially if diagnosed under age 60, or those from families where breast/ovarian/pancreatic cancers co-occur (suggesting a broader hereditary syndrome). The is also valuable for men diagnosed with metastatic prostate cancer to guide targeted therapy options or for at-risk individuals seeking peace of mind through proactive risk assessment, always under specialist supervision.
ج: الرجال الذين لديهم تاريخ عائلي قوي للإصابة بسرطان البروستاتا أو طفرات STAG1 المعروفة يجب أن يستشيروا طبيب الأورام.
Operated under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and Facility License 9834453. All services comply with Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Consumer Data Protection Law (PDPL), and CDS Law 2026 (Minors). Genetic counselling is a prerequisite; results are for clinical interpretation only.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians